摘要
α-葡萄糖苷酶抑制剂是20世纪70年代后期研究开发的一类新型口服降血糖药物,具有作用温和持久、毒副作用小甚至无毒的优点,是近年来药物治疗糖尿病的研究热点之一。中药是我国特色的药物资源,从中药资源中寻找α-葡萄糖苷酶抑制剂的研究则是我国新药研究的特色。专利是新药开发产品化过程中标志性的知识产权和技术文献。通过相关中国专利及相关文献分析,综述中药源α-葡萄糖苷酶抑制剂新药开发的现状。
α-glucosidase inhibitor is a new oral hypoglycemic drug researched and developed in the late 1970s,with mild and persistent effect,little side-effect, even non- toxicity,which is one of the hot points of diabetic pharmacotherapy in recent years. The Chinese herbal medicine as the Chinese characteristics drug resource is becoming the new drug research way,it is our characteristics research to find α- glucosidase inhibitor from Chinese medicine. Patent is the key intellectual property and technical literature in the process of new drug development. By analyzing the relevant Chinese patents and literature, the development status quo of Chinese medicinal new drug of α- glucosidase is reviewed.
出处
《中国药业》
CAS
2012年第24期15-16,共2页
China Pharmaceuticals
关键词
Α-葡萄糖苷酶抑制剂
专利
新药
中药
α- glucosidase inhibitor
patent
new drug
Chinese medicine
